Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | farnesyltransferase, CAAX box, beta | References | |
Homo sapiens | farnesyltransferase, CAAX box, alpha | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.03 | 0.2604 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0056 | 0.0062 | 0.0699 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.03 | 0.2604 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0131 | 0.0845 | 0.5682 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0056 | 0.0062 | 0.0699 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0072 | 0.0234 | 0.0898 |
Echinococcus multilocularis | protein farnesyltransferase alpha subunit | 0.0193 | 0.1488 | 1 |
Echinococcus multilocularis | multidrug and toxin extrusion protein 2 | 0.0056 | 0.0062 | 0.0414 |
Brugia malayi | Blistered cuticle protein 3 | 0.0072 | 0.0234 | 0.0898 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0056 | 0.0062 | 0.0699 |
Echinococcus multilocularis | Multi antimicrobial extrusion protein MatE | 0.0051 | 0.0011 | 0.0071 |
Leishmania major | hypothetical protein, conserved | 0.0056 | 0.0062 | 0.0699 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative | 0.0143 | 0.0967 | 0.65 |
Brugia malayi | Trypsin family protein | 0.03 | 0.2604 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0131 | 0.0845 | 0.5682 |
Trypanosoma cruzi | membrane transporter protein, putative | 0.0056 | 0.0062 | 0.0699 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Trichomonas vaginalis | type I geranylgeranyltransferase beta subunit, putative | 0.0135 | 0.0881 | 0.5917 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit, putative | 0.0193 | 0.1488 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0072 | 0.0234 | 0.0898 |
Giardia lamblia | Rab geranylgeranyltransferase | 0.0193 | 0.1488 | 1 |
Giardia lamblia | Prenyltransferase | 0.0135 | 0.0881 | 0.5917 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0131 | 0.0845 | 0.5682 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0072 | 0.0234 | 0.0898 |
Leishmania major | farnesyltransferase beta subunit | 0.0135 | 0.0881 | 1 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0135 | 0.0881 | 0.9104 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0131 | 0.0845 | 0.5682 |
Brugia malayi | Animal haem peroxidase family protein | 0.0072 | 0.0234 | 0.0898 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.101 | 1 | 0.5 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0072 | 0.0234 | 0.0898 |
Onchocerca volvulus | Peroxidasin homolog | 0.0072 | 0.0234 | 0.0898 |
Echinococcus granulosus | protein farnesyltransferase alpha subunit | 0.0193 | 0.1488 | 1 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0135 | 0.0881 | 0.5917 |
Schistosoma mansoni | multidrug resistance protein | 0.0056 | 0.0062 | 0.0236 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0072 | 0.0234 | 0.0898 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.101 | 1 | 0.5 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0135 | 0.0881 | 1 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0135 | 0.0881 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Brugia malayi | Peroxidasin | 0.0072 | 0.0234 | 0.0898 |
Brugia malayi | Protein prenyltransferase alpha subunit repeat containing protein | 0.0193 | 0.1488 | 0.5716 |
Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0135 | 0.0881 | 0.3382 |
Echinococcus multilocularis | protein farnesyltransferase subunit beta | 0.0135 | 0.0881 | 0.5917 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0056 | 0.0062 | 0.0699 |
Brugia malayi | Animal haem peroxidase family protein | 0.0072 | 0.0234 | 0.0898 |
Brugia malayi | Animal haem peroxidase family protein | 0.0072 | 0.0234 | 0.0898 |
Plasmodium falciparum | protein farnesyltransferase subunit alpha | 0.0193 | 0.1488 | 0.1488 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Onchocerca volvulus | Peroxidase homolog | 0.0072 | 0.0234 | 0.0898 |
Toxoplasma gondii | hypothetical protein | 0.0143 | 0.0967 | 1 |
Echinococcus granulosus | multidrug and toxin extrusion protein 2 | 0.0056 | 0.0062 | 0.0414 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Loa Loa (eye worm) | hypothetical protein | 0.0193 | 0.1488 | 0.5716 |
Onchocerca volvulus | 0.0072 | 0.0234 | 0.0898 | |
Echinococcus multilocularis | peroxidasin | 0.0072 | 0.0234 | 0.1571 |
Trypanosoma brucei | protein farnesyltransferase beta subunit | 0.0135 | 0.0881 | 1 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0135 | 0.0881 | 0.5917 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.101 | 1 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0072 | 0.0234 | 0.0898 |
Onchocerca volvulus | 0.0072 | 0.0234 | 0.0898 | |
Echinococcus granulosus | peroxidasin | 0.0072 | 0.0234 | 0.1571 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0072 | 0.0234 | 0.0898 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0056 | 0.0062 | 0.0699 |
Trichomonas vaginalis | geranylgeranyl transferase type I beta subunit, putative | 0.0135 | 0.0881 | 0.5917 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0056 | 0.0062 | 0.0699 |
Schistosoma mansoni | protein farnesyltransferase alpha subunit | 0.0193 | 0.1488 | 0.5716 |
Loa Loa (eye worm) | prenyltransferase alpha subunit repeat containing protein | 0.0193 | 0.1488 | 0.5716 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Trypanosoma brucei | MATE efflux family protein, putative | 0.0056 | 0.0062 | 0.0699 |
Onchocerca volvulus | 0.0072 | 0.0234 | 0.0898 | |
Brugia malayi | Prenyltransferase and squalene oxidase repeat family protein | 0.0135 | 0.0881 | 0.3382 |
Brugia malayi | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Onchocerca volvulus | 0.0275 | 0.2341 | 0.899 | |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.101 | 1 | 1 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative | 0.0193 | 0.1488 | 1 |
Schistosoma mansoni | peroxidasin | 0.0072 | 0.0234 | 0.0898 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0131 | 0.0845 | 0.5682 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0056 | 0.0062 | 0.0699 |
Loa Loa (eye worm) | hypothetical protein | 0.03 | 0.2604 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.101 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0135 | 0.0881 | 0.5917 |
Onchocerca volvulus | Peroxidasin homolog | 0.0072 | 0.0234 | 0.0898 |
Entamoeba histolytica | protein farnesyltransferase beta subunit, putative | 0.0135 | 0.0881 | 0.5917 |
Plasmodium vivax | prenyltransferase alpha subunit, putative | 0.0193 | 0.1488 | 0.1488 |
Trichomonas vaginalis | geranylgeranyl transferase type beta subunit, putative | 0.0135 | 0.0881 | 0.5917 |
Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0135 | 0.0881 | 0.0881 |
Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0135 | 0.0881 | 0.0881 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0056 | 0.0062 | 0.0699 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.101 | 1 | 0.5 |
Entamoeba histolytica | protein farnesyltransferase alpha subunit, putative | 0.0193 | 0.1488 | 1 |
Plasmodium vivax | conserved Plasmodium protein, unknown function | 0.0098 | 0.05 | 0.05 |
Loa Loa (eye worm) | prenyltransferase and squalene oxidase repeat family protein | 0.0135 | 0.0881 | 0.3382 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.101 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.03 | 0.2604 | 1 |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0072 | 0.0234 | 0.0898 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0234 | 0.0898 |
Echinococcus granulosus | protein farnesyltransferase subunit beta | 0.0135 | 0.0881 | 0.5917 |
Leishmania major | hypothetical protein, conserved | 0.0056 | 0.0062 | 0.0699 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit, putative | 0.0193 | 0.1488 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.03 | 0.2604 | 1 |
Onchocerca volvulus | Dual oxidase homolog | 0.0072 | 0.0234 | 0.0898 |
Schistosoma mansoni | peroxidasin | 0.0072 | 0.0234 | 0.0898 |
Brugia malayi | Animal haem peroxidase family protein | 0.0072 | 0.0234 | 0.0898 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | = 221 uM.min | AUC in BALB/c mouse at 50 mg/kg, po | ChEMBL. | 17606674 |
Cmax (ADMET) | = 4.2 uM | Cmax in BALB/c mouse at 50 mg/kg, po | ChEMBL. | 17606674 |
ED50 (functional) | = 15 nM | Antimalarial activity against Plasmodium falciparum K1 | ChEMBL. | 17722901 |
ED50 (functional) | = 15 nM | Antimalarial activity against Plasmodium falciparum in human red cells | ChEMBL. | 18198825 |
ED50 (functional) | = 15 nM | Antimalarial activity against Plasmodium falciparum K1 | ChEMBL. | 17722901 |
ED50 (functional) | = 15 nM | Antimalarial activity against Plasmodium falciparum in human red cells | ChEMBL. | 18198825 |
ED50 (functional) | = 16 nM | Antimalarial activity against Plasmodium falciparum 3D7 | ChEMBL. | 17722901 |
ED50 (functional) | = 16 nM | Antimalarial activity against Plasmodium falciparum | ChEMBL. | 18077162 |
ED50 (functional) | = 16 nM | Antimalarial activity against Plasmodium falciparum 3D7 | ChEMBL. | 17722901 |
ED50 (functional) | = 16 nM | Antimalarial activity against Plasmodium falciparum | ChEMBL. | 18077162 |
ED50 (functional) | = 16 nM | Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake | ChEMBL. | 17606674 |
ED50 (functional) | = 18 nM | Antiplasmodial activity against Plasmodium falciparum by [3H]hypoxanthine uptake | ChEMBL. | 17606674 |
IC50 (binding) | = 0.5 nM | Inhibition of Plasmodium falciparum PFT | ChEMBL. | 18198825 |
IC50 (binding) | = 0.58 nM | Inhibition of plasmodium falciparum protein farnesyltransferase by scintillation proximity assay | ChEMBL. | 17722901 |
IC50 (binding) | = 3.2 nM | Inhibition of protein farnesyltransferase | ChEMBL. | 17722901 |
IC50 (binding) | = 3.2 nM | Inhibition of protein farnesyltransferase | ChEMBL. | 17722901 |
Inhibition (binding) | Inhibition of 5HT2A receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of beta-1 adrenergic receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of alpha2 adrenergic receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of dopamine D2S receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of neuropeptide Y1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of NK2 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of 5HT1A receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of Galanin receptor type 2 at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of adenosine A3 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of mu opioid receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of dopamine D1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of CCR1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of 5HT5A receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of ETA receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of 5HT1B receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of dopamine central BZD receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of histamine H2 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of VIP1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of kappa opioid receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of MC4 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of muscarinic M3 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of CXCR2 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of melatonin MT1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of NK3 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of CCK1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of NET at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of 5HT6 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of adenosine A2A receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of bradykinin B2 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of histamine H1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of angiotensin AT1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of NTS1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of neuropeptide Y2 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of delta opioid receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of DAT at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of 5HT3 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of 5HT7 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of ORL1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | Inhibition of adenosine A1 receptor at 10 uM | ChEMBL. | 17606674 | |
Inhibition (binding) | = 61 % | Inhibition of plasmodium falciparum protein farnesyltransferase at 5 nM by scintillation proximity assay | ChEMBL. | 17722901 |
Inhibition (binding) | = 64 % | Inhibition of muscarinic M1 receptor at 10 uM | ChEMBL. | 17606674 |
Inhibition (binding) | = 77 % | Inhibition of muscarinic M2 receptor at 10 uM | ChEMBL. | 17606674 |
Inhibition (binding) | = 81 % | Inhibition of vasopressin V1a receptor at 10 uM | ChEMBL. | 17606674 |
Inhibition (binding) | = 96 % | Inhibition of plasmodium falciparum protein farnesyltransferase at 0.5 nM by scintillation proximity assay | ChEMBL. | 17722901 |
Inhibition (binding) | = 100 % | Inhibition of plasmodium falciparum protein farnesyltransferase at 50 nM by scintillation proximity assay | ChEMBL. | 17722901 |
permeability (ADMET) | = 1.1 10'-6 cm/s | Permeability from apical to basolateral side in human Caco-2 cells | ChEMBL. | 17606674 |
t1/2 (ADMET) | = 3.8 min | Metabolic stability assessed as half life in mouse liver microsomes | ChEMBL. | 18077162 |
T1/2 (ADMET) | = 3.8 min | Metabolic stability assessed as half life in mouse liver microsomes | ChEMBL. | 18077162 |
T1/2 (ADMET) | = 18 min | Elimination half life in BALB/c mouse at 50 mg/kg, po | ChEMBL. | 17606674 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.